Sustained Complete Molecular Remissions After Treatment With Imatinib-Mesylate in Patients With Failure After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia: Results of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback